Analytical instrumentation market forecasted to reach $89.58 billion by 2030

Jul. 23, 2026
By AI, Created 18:15 UTC, Jul 23, 2026, AGP -

The Business Research Company says the analytical instrumentation market will grow from $61.45 billion in 2025 to $89.58 billion by 2030, driven by pharmaceutical demand, lab automation and rising use across life sciences, food and environmental testing. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through 2030.

Why it matters: - Analytical instrumentation underpins research, quality control and regulatory compliance across pharmaceuticals, life sciences, diagnostics and industrial testing. - The market's projected climb to $89.58 billion by 2030 signals sustained demand for precise measurement tools, software-enabled systems and lab automation. - Growth in this market can ripple into healthcare, food safety, environmental monitoring and forensic testing.

What happened: - The Business Research Company released its "Analytical Instrumentation Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035" on July 24, 2026. - The report estimates the market at $61.45 billion in 2025. - The market is projected to reach $66.42 billion in 2026, a CAGR of 8.1%. - The report forecasts the market will hit $89.58 billion by 2030, growing at a 7.8% CAGR. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.

The details: - Analytical instrumentation includes devices that analyze the composition, structure and characteristics of materials or substances. - These tools provide measurements and data used to assess chemical, physical and biological samples. - Historical growth has come from reliance on traditional laboratory instruments, limited use of advanced software, expanding life sciences research, rising clinical and diagnostic testing, and greater use of spectroscopy and chromatography. - Future growth is expected to be driven by mass spectrometry, flow cytometry, sequencing, microarray technologies, laboratory automation, smart labs and software-enabled analytical systems. - The report flags rising demand for multi-application analytical platforms. - The report highlights growing needs for calibration and maintenance services. - The report points to increasing use in food, environmental and forensic testing. - The report also cites stronger emphasis on regulatory compliance and quality assurance. - The geographic scope covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report edition adds market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables. - The report offers a free sample here. - The full report is available here.

Between the lines: - The pharmaceutical sector is the clearest demand engine in the report, as drug development and compliance require high-precision instrumentation. - The report links market expansion to the shift from standalone lab hardware toward connected, software-led and automation-heavy workflows. - EFPIA reported in August 2025 that the pharmaceutical industry invested about $60,377.11 million (€52,400 million) in research and development across Europe in 2023, underscoring the sector's spending power.

What's next: - The market's next stage of growth will likely come from broader adoption of advanced analytics, automated labs and integrated software platforms. - Asia-Pacific's industrialization, healthcare buildout and research expansion could make it the main growth engine over the forecast period. - Vendors may compete more on compliance support, maintenance services and multi-use systems as end users look for efficiency and precision.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Medical Industry Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Medical Industry Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.